Testing effectiveness (Phase 2)Study completedNCT05216224
What this trial is testing
ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
Who this might be right for
Hidradenitis Suppurativa
Aclaris Therapeutics, Inc. 95